ArticleMolecular diagnosis & therapy2018

Cost Effectiveness of Karyotyping, Chromosomal Microarray Analysis, and Targeted Next-Generation Sequencing of Patients with Unexplained Global Developmental Delay or Intellectual Disability.

Yonghong Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.